TH-237A

CAS No. 935467-97-3

TH-237A( TH 237A | TH237A | meso-GS 164 )

Catalog No. M16689 CAS No. 935467-97-3

A novel, brain penetrant neuroprotective agent that protects neurons against β-amyloid (Aβ) induced neurotoxicity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 1176 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TH-237A
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel, brain penetrant neuroprotective agent that protects neurons against β-amyloid (Aβ) induced neurotoxicity.
  • Description
    A novel, brain penetrant neuroprotective agent that protects neurons against β-amyloid (Aβ) induced neurotoxicity; increases neuronal survival in the presence of the Aβ peptides in rat isolated neuronal culture with EC50 of 5 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TH 237A | TH237A | meso-GS 164
  • Pathway
    Others
  • Target
    Amyloids
  • Recptor
    Amyloids
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    935467-97-3
  • Formula Weight
    333.3293
  • Molecular Formula
    C18H17F2NO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 46 mg/mL
  • SMILES
    OC[C@@]12N([C@H](C3=CC=C(F)C=C3)OC2)[C@@H](C4=CC=C(F)C=C4)OC1
  • Chemical Name
    1H,3H,5H-Oxazolo[3,4-c]oxazole-7a(7H)-methanol, 3,5-bis(4-fluorophenyl)-, (3R,5S)-rel-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kelly E. Desino. Improving Blood Brain Barrier Permeation of Small Molecules Exhibiting Chemotherapeutic and Neuroprotective Effects.
molnova catalog
related products
  • Aβ polymerization st...

    Aβ polymerization stimulator O4 is an orcein-related small molecule can drive polymerization of amyloid-β (Aβ).

  • BNC-1

    BNC-1 is a small molecule modulator of Amyloid pathology by promoting phosphorylation and activation of Elk-1.

  • PE859

    PE859 is a novel, orally active tau aggregation inhibitor that inhibits the heparin-induced aggregation of both 3RMBD and full length tau with IC50 of 0.81 uM and 2.23 uM, respectively.